Save time and get answers to complex questions with AI chat
Symbravo ingredients mechanism of action?Is guselkumab off patent in u s?When genetic tenofovir alafenamide be available in us?Mobic injection patent oehringer ingelheim france?Testosterone enanthate expiration?
See the DrugPatentWatch profile for caplyta
Caplyta (lumateperone) is manufactured by Piramal Pharma Solutions in India and supplied under contract manufacturing arrangements for the product’s global market [1].
Caplyta’s marketing authorization holder is AbbVie, but manufacturing is carried out through contract manufacturing facilities—one of which is the Piramal Pharma Solutions site in India [1].
Public sources tie Caplyta manufacturing to Piramal Pharma Solutions (India), but they do not consistently name the specific facility address/plant designation in the same way across product documentation [1].
For the most precise confirmation, check the package insert or outer carton label for the country of supply and the named manufacturing site, because labeling can vary by market even when the same supplier is used [1]. Sources: [1] https://drugpatentwatch.com/brand/caplyta
Other Questions About Caplyta :